
Artivion, Inc. – NYSE:AORT
Artivion stock price today
Artivion stock price monthly change
Artivion stock price quarterly change
Artivion stock price yearly change
Artivion key metrics
Market Cap | 1.18B |
Enterprise value | 860.79M |
P/E | -27.63 |
EV/Sales | 2.74 |
EV/EBITDA | 33.51 |
Price/Sales | 1.73 |
Price/Book | 1.91 |
PEG ratio | 1.04 |
EPS | -0.24 |
Revenue | 368.20M |
EBITDA | 32.55M |
Income | -9.62M |
Revenue Q/Q | 17.06% |
Revenue Y/Y | 15.13% |
Profit margin | -6.12% |
Oper. margin | 1.98% |
Gross margin | 64.54% |
EBIT margin | 1.98% |
EBITDA margin | 8.84% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeArtivion stock price history
Artivion stock forecast
Artivion financial statements
$31.5
Potential downside: -25.03%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 89.25M | -3.38M | -3.79% |
---|---|---|---|
Sep 2023 | 87.85M | -9.80M | -11.16% |
Dec 2023 | 93.67M | -3.97M | -4.24% |
Mar 2024 | 97.43M | 7.53M | 7.73% |
Jun 2023 | 777861000 | 495.35M | 63.68% |
---|---|---|---|
Sep 2023 | 774787000 | 502.81M | 64.9% |
Dec 2023 | 792397000 | 510.61M | 64.44% |
Mar 2024 | 784007000 | 489.02M | 62.37% |
Jun 2023 | 6.90M | 7.07M | 2.23M |
---|---|---|---|
Sep 2023 | 7.23M | -2.06M | -909K |
Dec 2023 | 10.58M | -2.66M | -1.38M |
Mar 2024 | -15.49M | -3.61M | 10.73M |
Artivion alternative data
Aug 2023 | 1,300 |
---|---|
Sep 2023 | 1,300 |
Oct 2023 | 1,300 |
Nov 2023 | 1,300 |
Dec 2023 | 1,300 |
Jan 2024 | 1,300 |
Feb 2024 | 1,300 |
Mar 2024 | 1,500 |
Apr 2024 | 1,500 |
May 2024 | 1,500 |
Jun 2024 | 1,500 |
Jul 2024 | 1,500 |
Artivion other data
Period | Buy | Sel |
---|---|---|
Jan 2024 | 0 | 34791 |
Feb 2024 | 0 | 107355 |
Mar 2024 | 0 | 61699 |
May 2024 | 0 | 2229 |
Aug 2024 | 0 | 24679 |
Oct 2024 | 0 | 12430 |
Dec 2024 | 0 | 16372 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | HORTON AMY officer: VP, Chief Accounting O.. | Common Stock | 4,329 | $29.66 | $128,398 | ||
Sale | HORTON AMY officer: VP, Chief Accounting O.. | Common Stock | 4,425 | $29.05 | $128,551 | ||
Sale | GREEN ANDREW M officer: VP Regulatory | Common Stock | 7,618 | $30 | $228,540 | ||
Option | HORTON AMY officer: VP, Chief Accounting O.. | Common Stock | 12,430 | $21.55 | $267,867 | ||
Sale | HORTON AMY officer: VP, Chief Accounting O.. | Common Stock | 12,430 | $26.18 | $325,417 | ||
Option | HORTON AMY officer: VP, Chief Accounting O.. | Stock Option (Right to Buy) | 12,430 | $21.55 | $267,867 | ||
Sale | HOLLOWAY JEAN F officer: SVP, Gen.. | Common Stock | 3,167 | $26.55 | $84,097 | ||
Sale | GETZ MATTHEW A officer: VP, Human Resources | Common Stock | 6,858 | $25.31 | $173,590 | ||
Sale | GETZ MATTHEW A officer: VP, Human Resources | Common Stock | 2,562 | $25.31 | $64,849 | ||
Sale | HOLLOWAY JEAN F officer: SVP, Gen.. | Common Stock | 2,383 | $25.76 | $61,393 |
Quarter | Transcript |
---|---|
Q1 2024 6 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 15 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 5 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 5 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Artivion stock today?
One share of Artivion stock can currently be purchased for approximately $42.02.
-
When is Artivion's next earnings date?
Unfortunately, Artivion's (AORT) next earnings date is currently unknown.
-
Does Artivion pay dividends?
No, Artivion does not pay dividends.
-
How much money does Artivion make?
Artivion has a market capitalization of 1.18B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 12.82% to 354M US dollars.
-
What is Artivion's stock symbol?
Artivion, Inc. is traded on the NYSE under the ticker symbol "AORT".
-
What is Artivion's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Artivion?
Shares of Artivion can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Artivion have?
As Jul 2024, Artivion employs 1,500 workers.
-
When Artivion went public?
Artivion, Inc. is publicly traded company for more then 32 years since IPO on 12 Feb 1993.
-
What is Artivion's official website?
The official website for Artivion is artivion.com.
-
Where are Artivion's headquarters?
Artivion is headquartered at 1655 Roberts Boulevard N.W., Kennesaw, GA.
-
How can i contact Artivion?
Artivion's mailing address is 1655 Roberts Boulevard N.W., Kennesaw, GA and company can be reached via phone at +7 704193355.
-
What is Artivion stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for Artivion in the last 12 months, the avarage price target is $31.5. The average price target represents a -25.03% change from the last price of $42.02.
Artivion company profile:

Artivion, Inc.
artivion.comNYSE
1,500
Medical - Devices
Healthcare
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.
Kennesaw, GA 30144
CIK: 0000784199
ISIN: US2289031005
CUSIP: 228903100